Synthesis of new 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H- pyrazole derivatives as potential antimicrobial agents
| dc.contributor.author | Malladi, S. | |
| dc.contributor.author | Isloor, A.M. | |
| dc.contributor.author | Peethambar, S.K. | |
| dc.contributor.author | Fun, H.-K. | |
| dc.date.accessioned | 2026-02-05T09:34:46Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | New (E)-1-aryl-3-(3-aryl-1-phenyl-1H-pyrazol-4-yl)prop-2-en-1-ones 6 (pyrazolic chalcones) were synthesized from Claisen-Schmidt reaction of 3-aryl-1-phenylpyrazol-4-carboxaldehydes 4 with several acetophenone derivatives 5. Subsequently, the cyclocondensation reaction of chalcones 6 with phenylhydrazine in acetic acid medium afforded the new 3-aryl-4-(3-aryl-4,5- dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazoles 7. The synthesized compounds were characterized by spectral studies and evaluated for their in vitro antibacterial activity against three pathogenic bacterial strains, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, and in vitro antifungal activity against three pathogenic fungal strains Aspergillus flavus, Chrysosporium keratinophilum, and Candida albicans. © 2012 Springer Science+Business Media New York. | |
| dc.identifier.citation | Medicinal Chemistry Research, 2013, 22, 6, pp. 2654-2664 | |
| dc.identifier.issn | 10542523 | |
| dc.identifier.uri | https://doi.org/10.1007/s00044-012-0267-8 | |
| dc.identifier.uri | https://idr.nitk.ac.in/handle/123456789/26780 | |
| dc.subject | 3 (4 bromophenyl) 1 phenyl 4 (1 phenyl 3 biphenyl 4,5 dihydro 1h pyrazol 5 yl) 1h pyrazole | |
| dc.subject | 3 (4 bromophenyl) 4 [3 (2,4 dichlorophenyl) 1 phenyl 4,5 dihydro 1h pyrazol 5 yl] 1 pheny 1h pyrazole | |
| dc.subject | 3 (4 bromophenyl) 4 [3 [4 (methylthio)phenyl] 1 phenyl 4,5 dihydro 1h pyrazol 5 yl] 1 phenyl 1h pyrazole | |
| dc.subject | 3 (4 chlorophenyl) 1 phenyl 4 (1 phenyl 3 biphenyl 4,5 dihydro 1h pyrazol 5 yl) 1h pyrazole | |
| dc.subject | 3 (4 chlorophenyl) 4 [3 (2,4 dichlorophenyl) 1 phenyl 4,5 dihydro 1h pyrazol 5 yl] 1 pheny 1h pyrazole | |
| dc.subject | 3 (4 chlorophenyl) 4 [3 [4 (methylthio)phenyl] 1 phenyl 4,5 dihydro 1h pyrazol 5 yl] 1 phenyl 1h pyrazole | |
| dc.subject | 3 (4 methoxyphenyl) 1 phenyl 4 (1 phenyl 3 biphenyl 4,5 dihydro 1h pyrazol 5 yl) 1h pyrazole | |
| dc.subject | 3 (4 methoxyphenyl) 4 [3 [4 (methylthio)phenyl] 1 phenyl 4,5 dihydro 1h pyrazol 5 yl] 1 phenyl 1h pyrazole | |
| dc.subject | 3 aryl 4 (3 aryl 4,5 dihydro 1h pyrazol 5 yl) 1 phenyl 1h pyrazole derivative | |
| dc.subject | 4 [3 (2,4 dichlorophenyl) 1 phenyl 4,5 dihydro 1h pyrazol 5 yl] 1,3 diphenyl 1h pyrazole | |
| dc.subject | 4 [3 (2,4 dichlorophenyl) 1 phenyl 4,5 dihydro 1h pyrazol 5 yl] 3 (4 methoxyphenyl) 1 phenyl 1h pyrazole | |
| dc.subject | 4 [3 [4 (methylthio)phenyl] 1 phenyl 4,5 dihydro 1h pyrazol 5 yl] 1,3 dipheyl 1h pyrazole | |
| dc.subject | antibiotic agent | |
| dc.subject | antifungal agent | |
| dc.subject | fluconazole | |
| dc.subject | pyrazole derivative | |
| dc.subject | streptomycin | |
| dc.subject | unclassified drug | |
| dc.subject | antibacterial activity | |
| dc.subject | antifungal activity | |
| dc.subject | article | |
| dc.subject | Aspergillus flavus | |
| dc.subject | Candida albicans | |
| dc.subject | chrysosporium keratinophilum | |
| dc.subject | controlled study | |
| dc.subject | drug synthesis | |
| dc.subject | Escherichia coli | |
| dc.subject | fungus | |
| dc.subject | in vitro study | |
| dc.subject | infrared spectroscopy | |
| dc.subject | nonhuman | |
| dc.subject | proton nuclear magnetic resonance | |
| dc.subject | Pseudomonas aeruginosa | |
| dc.subject | Staphylococcus aureus | |
| dc.title | Synthesis of new 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H- pyrazole derivatives as potential antimicrobial agents |
